Ophthalmology News

Among individuals who were prescribed approved biologics for neuromyelitis optica spectrum disorder, those on inebilizumab had significantly higher medication adherence, according to a study presented at ECTRIMS 2024.

BARCELONA, Spain — One-year results with the second-generation ELZA-sub400 protocol for corneal cross-linking showed efficacy in halting keratoconus progression in ultrathin corneas, according to a study presented here.

Being self-employed and having multiple revenue streams can help an ophthalmologist set themselves up for financial stability, according to a presentation at Real World Ophthalmology.

In this video, Barbara Blodi, MD, discusses early data on neuroprotective agents for the treatment of geographic atrophy.

BARCELONA, Spain — Adopting specific treatment regimens, reducing patient and staff travel, and limiting the use of unnecessary personal protective equipment can help improve the carbon footprint of intravitreal injections.

BARCELONA, Spain — In this Healio Video Perspective from the European Society of Cataract and Refractive Surgeons meeting, Rosa Giglio, MD, shares study results investigating the Tecnis Eyhance IOL from Johnson & Johnson Vision.

EssilorLuxottica has completed its acquisition of an 80% stake in Heidelberg Engineering, according to a company press release.

In this video, Barbara Blodi, MD, discusses advancements in complement inhibition treatments for geographic atrophy.

The FDA approved the enVista Envy full range of vision IOL from Bausch + Lomb, according to a press release.

CARLSBAD, Calif. — Retinal detachment repair in pediatric patients yielded favorable anatomic and visual outcomes compared with no intervention, according to a poster presented at the Women in Ophthalmology Summer Symposium.